
    
      Key of this prospective study is to identify a potentially increased cardiovascular risk in
      patients with systemic Lupus erythematodes, with and without renal affection. Three group of
      patients will be compared as followed. First group are patients with known systemic Lupus
      erythematodes without renal affection, second group are patients with known systemic Lupus
      erythematodes with renal affection and the third group are patients with a non-autoimmun
      chronic kidney disease
    
  